Apart from a recent study suggesting a role in glioma progression and therapeutical resistance [56], little is known about the role of KAT6B in glioma, a lysine acetyltransferase of the MYST family with oncogenic or tumor suppressor properties depending on the cancer [57]. Here, KAT6B is linked to neoplasm.